| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AMN | Common Stock | Options Exercise | $0 | +889 | +4.79% | $0.00 | 19.5K | Jan 6, 2023 | Direct | F1 |
| transaction | AMN | Common Stock | Tax liability | -$39.6K | -370 | -1.9% | $107.16 | 19.1K | Jan 6, 2023 | Direct | F2 |
| transaction | AMN | Common Stock | Sale | -$110K | -1K | -5.25% | $109.30 | 18.1K | Jan 6, 2023 | Direct | F3, F4 |
| transaction | AMN | Common Stock | Sale | -$443K | -4K | -22.13% | $110.76 | 14.1K | Jan 9, 2023 | Direct | F5, F6 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AMN | Restricted Stock Units | Options Exercise | $0 | -1.26K | -100% | $0.00* | 0 | Jan 6, 2023 | Common Stock | 1.26K | Direct | F7, F8, F9 |
| Id | Content |
|---|---|
| F1 | Common Stock acquired on the vesting of Restricted Stock Units. |
| F2 | Number of shares withheld for tax purposes. |
| F3 | The sale of 1,002 shares of AMN Common Stock was affected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. |
| F4 | The price reported in this row represents a weighted average price of $109.30 per share. These shares were sold in multiple transactions at prices ranging from $109.30 to $109.31, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. |
| F5 | The sale of 4,001 shares of AMN Common Stock was affected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. |
| F6 | The price reported in this row represents a weighted average price of $110.76 per share. These shares were sold in multiple transactions at prices ranging from $110.41 to $111.04, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. |
| F7 | The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. |
| F8 | The Restricted Stock Units identified in this row were granted on January 6, 2020 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service. |
| F9 | Restricted Stock Units do not have an expiration date. |